ACS-COVID-19-Assiut Clinical Trial
Official title:
Assiut University Registry for ACS Patients During COVID-19 Pandemic
To register pathological events occurring to all acute coronary syndrome patients coming to Assiut university heart hospital through one year during COVID- 19 pandemic
Status | Recruiting |
Enrollment | 2500 |
Est. completion date | September 2023 |
Est. primary completion date | March 2023 |
Accepts healthy volunteers | |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - Patients presenting with symptoms or ECG indicative of acute coronary syndrome admitted to Assiut heart hospital Exclusion Criteria: - The only exclusion criteria is refusal of the patient to participate in the study |
Country | Name | City | State |
---|---|---|---|
Egypt | Samah ObiedAllah Fouad | Assiut | Resident |
Lead Sponsor | Collaborator |
---|---|
Assiut University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Main Number, distribution and oucome of all ACS patients coming to Assiut heart hospital | Number, distribution and outcome of all ACS patients coming to Assiut heart hospital(as age, gender, risk factors of coronary artery diseases and their effect on incidence and progress of ACS ) | about 1 year | |
Secondary | To register pathological events occurring to all acute coronary syndrome patients coming to Assiut university heart hospital through one year during COVID- 19 pandemic | To evaluate clinical symptoms and signs of COVID -19 and acute coronary syndrome(Type of ACS, type of intervention or treatment for each case,complications if peresent, COVID - 19 status and if it affects ACS patient or not and follow up after 3 months and 1 year) | about 1 year |